Eliquis had a market value of $14 billion during the 12 months ended May 2021, according to industry data. The Food and Drug Administration has cleared Breckenridge’s apixaban tablets. The medication ...

DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Eliquis" report has been added to ResearchAndMarkets.com's offering. Eliquis (Apixaban; Bristol-Myers Squibb/Pfizer) is an orally available factor Xa ...

The Food and Drug Administration has approved two applications for the first generics of Bristol-Myers Squibb's Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in ...

FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Bristol Myers Squibb and Pfizer will begin offering ...

Bristol-Myers Squibb Laura Hortas, 609-252-4587, John Elicker, 609-252-4611, orPfizer Inc.MacKay Jimeson, 212-733-2324, Suzanne Harnett, 212-733-8009, (NYSE: BMY) and (NYSE: PFE) today announced that ...

Shares of Mylan are up 0.2% in premarket trading on Tuesday. The Food and Drug Administration said Monday that the company and Micro Labs Ltd., a privately held generic drugmaker, had each received ...

SILVER SPRING, Md., Dec. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke ...

FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS ...